Atricure Inc. buy BTIG Research
Start price
18.02.26
/
50%
€27.40
Target price
18.02.27
€45.59
Performance (%)
-13.87%
Price
05.06.26
€23.00
Summary
This prediction is currently active. The prediction for Atricure Inc. disappoints with a performance of -13.87%. This prediction currently runs until 18.02.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -2.542% | -2.542% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by BTIG_Research for this prediction
In the thread Atricure Inc. diskutieren
AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $54.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat